![]() Geneseeq Geneseeq Technology (also known as 世和基因, Geneseeq Tech) is a biotech company that is focused on the research and clinical translation of next-generation sequencing (NGS) in the field of personalized medicine. | ![]() Full Genomes Full Genomes is a company that combines sequencing technology to generate reports for customers' ancestry and genealogy, using full sequencing of the Y chromosome as well as other products. | ![]() SageMedic SageMedic is a company developing a test to predict, which chemotherapy is most likely to be effective to improve patient's chances for tumor response and long-term survival. | ![]() CellCarta CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. | ||
Founding Date | Founding Date 2008 | Founding Date 2012 | Founding Date 2015 | Founding Date 2017 | Founding Date 2001 |
Type | Type Private | Type Private | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Toronto, CA HQ | Locations Rockville, US HQ | Locations Noáin, ES HQ Madrid, ES Pamplona, ES | Locations Redwood City, US HQ | Locations Antwerpen, BE HQ Berchem, BE Naperville, US |
Employees | Employees 338% decrease | Employees 6 | Employees 4 | Employees 8 | Employees 4 |
Funding | |||||
Latest funding round | Latest funding round $ 114.4m (over 6 years ago) | Latest funding round $ 19.1k (about 10 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 135.6m | Total funding raised $ 602.1k | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A |

Full Genomes is a company that combines sequencing technology to generate reports for customers' ancestry and genealogy, using full sequencing of the Y chromosome as well as other products.
View companyIkan Biotech is a company that specializes in vivo models and antimicrobial products.
View company
SageMedic is a company developing a test to predict, which chemotherapy is most likely to be effective to improve patient's chances for tumor response and long-term survival.
View company
CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory.
View company